Regenerative Potential of the Product “CardioCell” Derived from the Wharton’s Jelly Mesenchymal Stem Cells for Treating Hindlimb Ischemia

In recent years, mesenchymal stem cells (MSCs) have emerged as a promising therapeutic modality in regenerative medicine. They hold great promise for treating civilization-wide diseases, including cardiovascular diseases, such as acute myocardial infarction and critical limb ischemia. MSCs isolated...

Descripción completa

Detalles Bibliográficos
Autores principales: Musiał-Wysocka, Aleksandra, Kot, Marta, Sułkowski, Maciej, Majka, Marcin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6770009/
https://www.ncbi.nlm.nih.gov/pubmed/31540534
http://dx.doi.org/10.3390/ijms20184632

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6770009/
https://www.ncbi.nlm.nih.gov/pubmed/31540534
http://dx.doi.org/10.3390/ijms20184632

Ejemplares similares